Evidence map›Paper›PMID 33619969›Full record

ArticleJournal of the American Heart Association2021

Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative.

Bernhard Haring, Alexander P Reiner, Jingmin Liu, Deirdre K Tobias, Eric Whitsel, Jeffrey S Berger, Pinkal Desai, Sylvia Wassertheil-Smoller, Michael J LaMonte, Kathleen M Hayden and 9 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Exacerbation of inflammatory bone loss in TET2-driven clonal hematopoiesis.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  5. Article
  6. Risk factors of clonal hematopoiesis of indeterminate potential.Clinical medicine (London, England) · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  18. Review
  19. Review
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 16 institutions in 2 countries.

Bernhard HaringDepartment of Internal Medicine I University of Würzburg Bavaria Germany.
Alexander P ReinerDivision of Public Health Sciences Department of Epidemiology Fred Hutchinson Cancer Research CenterUniversity of Washington Seattle WA.
Jingmin LiuWomen's Health Initiative Seattle WA.
Deirdre K TobiasDepartment of Nutrition Harvard T.H. Chan School of Public Health Boston MA.
Eric WhitselDepartment of Epidemiology and Medicine University of North Carolina Chapel Hill NC.
Jeffrey S BergerDepartment of Medicine Center for the Prevention of Cardiovascular Disease New York University School of Medicine New York City NY.
Pinkal DesaiDivision of Hematology and Oncology Weill Cornell Medical College New York NY.
Sylvia Wassertheil-SmollerDepartment of Epidemiology and Population Health Albert Einstein College of Medicine Bronx NY.
Michael J LaMonteDepartment of Epidemiology and Environmental Health School of Public Health and Health Professions University at Buffalo-SUNY Buffalo NY.
Kathleen M HaydenDivision of Public Health Sciences Department of Social Sciences and Health Policy Wake Forest School of Medicine Winston-Salem NC.
Alexander G BickDepartment of Medicine Program in Medical and Population Genetics Harvard Medical SchoolBroad Institute of Harvard and MIT Cambridge MA.
Pradeep NatarajanDepartment of Medicine Program in Medical and Population Genetics Harvard Medical SchoolBroad Institute of Harvard and MIT Cambridge MA.
Joshua S WeinstockDepartment of Biostatistics and Center for Statistical Genetics University of Michigan School of Public Health Ann Arbor MI.
Patricia K NguyenDepartment of Medicine Stanford University Medical Center Palo Alto CA.
Marcia StefanickDepartment of Medicine Stanford University Medical Center Palo Alto CA.
Michael S SimonDepartment of Oncology Karmanos Cancer Institute at Wayne State University Detroit MI.
Charles B EatonDepartment of Epidemiology Center for Primary Care and Prevention Brown University Providence RI.
Charles KooperbergFred Hutchinson Cancer Research Center Seattle WA.
JoAnn E MansonDivision of Preventive Medicine Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA.
Brigham and Women's Hospital · USBroad Institute · USStanford Medicine · USAlbert Einstein College of Medicine · USBrown University · USCornell University · USFred Hutch Cancer Center · USNew York University · USUniversity at Buffalo, State University of New York · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USUniversity of Würzburg · DEWake Forest University · USWayne State University · USWomen's Health Initiative · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Clonal hematopoiesis in the Womens Health Initiative Memory StudyR01HL148565 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ALEXANDER P REINER, Eric A. Whitsel · 2019 to 2026
$5.9M
Clonal hematopoiesis in humans: determinants of development and progressionR01HL148050 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE MITCHELL, NATARAJAN, PRADEEP · 2019 to 2022
$5.9M
Targeting Clonal Hematopoiesis of Indeterminate Potential Using Human GeneticsDP5OD029586 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BICK, ALEXANDER · 2020 to 2024
$2.3M
NCATS NIH HHS UL1 TR001412NHLBI NIH HHS HHSN268201600001CNHLBI NIH HHS HHSN268201600002CNHLBI NIH HHS HHSN268201600003CNHLBI NIH HHS HHSN268201600004CNHLBI NIH HHS HHSN268201600018CNHLBI NIH HHS R01 HL148050NHLBI NIH HHS R01 HL148565NIH HHS DP5 OD029586
6 · The paper itself

Abstract

Background Presence of clonal hematopoiesis of indeterminate potential (CHIP) is associated with a higher risk of atherosclerotic cardiovascular disease, cancer, and mortality. The relationship between a healthy lifestyle and CHIP is unknown. Methods and Results This analysis included 8709 postmenopausal women (mean age, 66.5 years) enrolled in the WHI (Women's Health Initiative), free of cancer or cardiovascular disease, with deep-coverage whole genome sequencing data available. Information on lifestyle factors (body mass index, smoking, physical activity, and diet quality) was obtained, and a healthy lifestyle score was created on the basis of healthy criteria met (0 point [least healthy] to 4 points [most healthy]). CHIP was derived on the basis of a prespecified list of leukemogenic driver mutations. The prevalence of CHIP was 8.6%. A higher healthy lifestyle score was not associated with CHIP (multivariable-adjusted odds ratio [OR] [95% CI], 0.99 [0.80-1.23] and 1.13 [0.93-1.37]) for the upper (3 or 4 points) and middle category (2 points), respectively, versus referent (0 or 1 point). Across score components, a normal and overweight body mass index compared with obese was significantly associated with a lower odds for CHIP (OR, 0.71 [95% CI, 0.57-0.88] and 0.83 [95% CI, 0.68-1.01], respectively;

Indexed as

Life StylePostmenopauseWomen's HealthAgedCardiovascular DiseasesClonal HematopoiesisDNAFemaleGene FrequencyHumansMiddle AgedPrevalenceRetrospective StudiesUnited StatesDNAbody mass indexclonal hematopoiesis of indeterminate potentialdietlifestylephysical activitysmoking

Identifiers

PMID33619969
PMCPMC8174283
OpenAlexW3130401772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.